NIH-funded research R01 grant

Predicting how cervical cancer patients will respond to radiation treatment

Official title: Integrating multi-omics, imaging, and longitudinal data to predict radiation response in cervical cancer

Funded at Washington University · NIH-10923978 · Data updated 2026-11-12

This study is looking to help doctors better predict how well cervical cancer patients will respond to their chemotherapy and radiation treatments by using different types of information, like genetic tests and scans, to find out who might need extra support early on.

More Cervical Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 7, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$481,595
NIH project number5R01CA276955-02
Project IDNIH-10923978 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women diagnosed with locally advanced cervical cancer who are about to undergo chemoradiation therapy.

Less likely to help

Patients with early-stage cervical cancer or those who are not receiving chemoradiation therapy may not benefit from this research.

What this research studies

This research aims to improve the prediction of treatment responses in cervical cancer patients undergoing chemoradiation therapy. By integrating various types of data, including genomic, imaging, and clinical information, the study seeks to identify patients at risk of treatment failure early on. The approach involves analyzing pre-treatment tumor biopsies and imaging data to develop biomarkers that can guide personalized treatment strategies. This could lead to more effective interventions tailored to individual patient needs.

Why it matters

Potential benefit: If successful, this research could lead to more personalized and effective treatment plans for cervical cancer patients, potentially improving survival rates.

How similar studies have gone: Previous research has shown promise in using integrated data approaches to improve cancer treatment outcomes, indicating that this method could be effective.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Zhang, Jin — Washington University
  • Study coordinator: Zhang, Jin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.